CommercialCoverageMedium impact
06.02.56i, Noninvasive Techniques for the Evaluation and Monitoring of Individuals with Chronic Liver Disease
Independence Blue Cross·Gastroenterology, Internal Medicine, Family Medicine·Medical Policy
Effective date
Jan 22, 2025
We identified it
Jun 19, 2026
Summary
IBX has reissued policy 06.02.56i regarding noninvasive techniques for evaluation and monitoring of chronic liver disease patients, effective January 22, 2025. This appears to be a commercial policy update, though specific changes are not detailed in the summary provided.
Action Required
By January 22, 2025: Billing team should review the full policy document at the provided URL to understand specific changes to coverage criteria for noninvasive liver disease monitoring techniques. Update billing workflows and prior authorization requirements as specified in the complete policy. Contact IBX or review full policy details for specific billing code and documentation requirements.